Epidemiology of invasive meningococcal disease in the United States: review of recent data and identified risk factors
The data indicate a rebound in IMD after the COVID-19 pandemic, highlighting the importance of strengthening surveillance and vaccination among high-risk populations.
Authors
- Jessica Presa (ORCID: https://orcid.org/0000-0002-8723-8980)
- Vincenza Snow (ORCID: https://orcid.org/0000-0002-0995-2185)
- Daniel L. Spitz
- Paul Balmer
Institutions
- Pfizer (United States) (US)
Publication Details
- Journal
- Frontiers in Public Health
- Published
- 2026-03-04
- DOI
- https://doi.org/10.3389/fpubh.2026.1694023
- Primary Topic
- Bacterial Infections and Vaccines
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer